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ABSTRACT 
OBJECTIVES:  Breathlessness is prevalent in older people. Symptom control at the end of life 
is important. This study investigated relationships between age, clinical characteristics and 
breathlessness sufficient to have people spend at least one half a day in that month in bed or 
cut down on their usual activities (restricting breathlessness) during the last year of life. 
DESIGN: Secondary data-analysis 
SETTING: General community 
PARTICIPANTS: 754 non-disabled persons, aged 70 and older. Monthly telephone interviews 
were conducted to determine the occurrence of restricting breathlessness. The primary 
outcome was the percentage of months with restricting breathlessness reported during the last 
year of life. 
RESULTS: Data regarding breathlessness were available for 548/589 (93.0%) decedents 
(mean age 86.7 years (range 71 to 106; males 38.8%). 311/548 (56.8%) reported restricting 
breathlessness at some time-point during the last year of life but no-one reported this every 
month. Frequency increased in the months closer to death irrespective of cause. Restricting 
breathlessness was associated with anxiety, (0.25 percentage point increase in months 
breathlessness per percentage point months reported anxiety, 95% CI 0.16 to 0.34, P<0.001), 
depression (0.14, 0.05 to 0.24, P=0.002) and mobility problems (0.07, 0.03 to 0.1, P=0.001). 
Percentage months of restricting breathlessness increased if chronic lung disease was noted at 
the most recent comprehensive assessment (6.62 percentage points, 95% CI 4.31 to 8.94, 
P<0.001), heart failure (3.34, 0.71 to 5.97, P<0.01), and ex-smoker status (3.01, 0.94 to 5.07, 
P=0.002), but decreased with older age (─0.19, ─0.37 to ─0.02, P=0.03).   
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CONCLUSION: Restricting breathlessness increased in this elderly population in the months 
preceding death from any cause. Breathlessness should be assessed and managed in the 
context of poor prognosis.   
Key words: dyspnea; breathlessness; prevalence; end of life; elderly;  
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INTRODUCTION 
Published estimates for the prevalence of breathlessness, medically known as dyspnea, in the 
general population vary between 9% to 59%, with a higher prevalence in older populations 
and in women.1-8 A large national primary care study found that one in three people seen by 
their family practitioner with breathlessness was over 75 years old.9  Common cardio-
respiratory conditions such as cancer,10 chronic non-malignant lung disease, and heart failure 
increase in prevalence with age and are common causes of breathlessness (60% - 88% with 
heart failure and 90% -  95%  with late stage chronic obstructive pulmonary disease).11  
Breathlessness worsens in the advanced stages of disease,12 and in the weeks prior to death.13 
Post-bereavement interviews among informal caregivers of people with lung cancer found 
that 78% of decedents had experienced breathlessness in their final year.14  
Breathlessness is a frightening symptom which limits all aspects of life and is associated with 
poor clinical outcomes. People with breathlessness are more likely to be sent to hospital from 
primary care,9 admitted to hospital from the emergency department,15 experience an in-
hospital serious event 16 and have a poorer prognosis.17-19 The relationship between 
breathlessness and mortality remains relevant for older age groups; in people aged 70 or over 
with breathlessness, both 2-year and 10-year survival are reduced.20 Good control of 
symptoms at the end of life is consistently rated as important by patients, caregivers, and 
health care providers.21 However, refractory breathlessness (breathlessness which persists 
despite optimal management of the underlying condition),22 is common and burdensome in 
many chronic cardio-respiratory conditions and cancer;12, 23 and is frequently neglected 
despite available effective interventions.24, 25 Breathlessness is likely to be particularly 
difficult for the elderly, where it adds burden to multiple chronic conditions with major 
6 
 
effects on mobility, activities of daily living, confidence, independence, care needs and the 
ability to remain in their own homes in those older people nearing the end of life. 
Despite associations between age and breathlessness, it is unknown whether breathlessness is 
primarily a feature of disease or of ageing.  
 
Aim and Objectives  
Using data from a cohort of community dwelling older people, we examined monthly 
patterns of reported difficulty breathing or shortness of breath sufficient to restrict activities 
(defined as stay in bed at least half a day, or cut down on their usual activities) during the last 
year of life (herein as restricting breathlessness). We investigated associations with clinical 
characteristics including “condition leading to death”, age and the dependent variable of 
restricting breathlessness reported longitudinally during the last year of life.  
The study’s objectives were to: describe the prevalence and temporal patterns of restricting 
breathlessness during the last year; describe the temporal patterns of restricting breathlessness 
in relation to conditions leading to death; and to identify the clinical and demographic 
characteristics associated with restricting breathlessness.  
 
Hypothesis 
Based on the literature, we hypothesized that several factors would be associated with 
restricting breathlessness during the last year of life, including the presence of co-morbid 
disease, cause of death, smoking status, age, sex, anxiety and depression.  
As this was a cohort of elderly people living at home (at study enrolment), this would include 
people who were medically fit but may have intercurrent illness, and those with chronic 
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conditions causing breathlessness. We anticipated that during the last year of life, there would 
also be people who developed a condition which led to their death.  Given the heterogeneity 
often observed in older persons, we also hypothesized that distinct trajectories of restricting 
breathlessness during the last year of life could be identified (no breathlessness; chronic 
[present at every month point]; intermittent; and crescendo breathlessness (started partway 
through the year and was continuously present until death).
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METHODS 
The study was approved by the human investigational committee at Yale University and 
participants provided verbal informed consent.  
 
Design 
This is a secondary analysis of data relating to the last year of life among decedents who had 
participated in a longitudinal cohort study of initially non-disabled, community-living 
persons 70 years of age or older when enrolled.26 
 
Study population 
The study cohort (n = 754) was identified from a computerized list of 3157 members of a 
large health plan in the United States of America. Sequential screening and enrollment was 
conducted between March 1998 and October 1999. Data collection is ongoing. Eligible plan 
members, 75.2% of whom agreed to participate, were English-speaking and could bathe, 
walk, dress, and transfer from a chair to standing without assistance at baseline. Those who 
did not agree to participate were not significantly different in terms of age or sex. Members 
were excluded if they had: a diagnosis of a terminal illness with an expected prognosis of less 
than 12 months; plans to move out of the study area during the next 12 months; or significant 
cognitive impairment with no available proxy.  
 
Sample for analysis 
Of the 589 participants who had died between October 1998 and June 2013, 41 had 
withdrawn from the study, leaving 548 (93%) with data on breathlessness in the last year of 
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life. Of these, 50 (9.1%) died within the first year of follow up and therefore had less than 
one year of data.  
 
Baseline data collection 
Comprehensive home-based assessments were completed at baseline and at 18-month 
intervals by trained nurses who used standard instruments to perform all interviews and 
assessments.  Data were collected on demographic characteristics and nine self-reported 
chronic conditions diagnosed by a physician (hypertension; myocardial infarction; congestive 
heart failure; stroke; diabetes; arthritis; hip fracture, chronic lung disease, cancer), cognition 
(Folstein Mini-Mental State Examination) and frailty.27  
 
Follow up data collection 
Telephone interviews were conducted monthly. For participants with significant cognitive 
impairment, data were collected from a proxy. Proxy assessments are valid for many 
measures, including breathlessness. 28, 29 Data were used from the comprehensive assessment 
that pre-dated death by at least one year and from the monthly interviews during the last year 
of life. Data for this current secondary analysis were collected until June 2013.  
 
Condition leading to death 
Decedents were identified through local obituary reviews, from the next of kin or another 
suitable informant during a subsequent telephone interview, or both. The classification of 
conditions leading to death is described elsewhere.30 The approach used by Lunney31 was 
modified by adding advanced dementia as a condition leading to death, and including chronic 
kidney disease and cirrhosis to the category of ‘organ failure’. Frailty, as a condition leading 
to death, was defined by the phenotype described by Fried et al32 using data from the 
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comprehensive assessments.  Where data from death certificates were obtained, diagnoses 
were the ‘immediate’ or ‘underlying cause’ of death.  
 
Assessment of restricting breathlessness  
This analysis relates to difficulty breathing that caused restriction in activity during the 
previous month.  During the monthly interviews, participants were asked if they had stayed in 
bed at least half a day or cut down on their usual activities due to an illness, injury, or other 
problem in the preceding month. Those who said ‘yes’ to either question (i.e. had restricted 
activity) were asked about a series of problems including whether they had experienced 
“difficulty breathing or shortness of breath since we last talked” and whether or not that 
problem caused restricted activity. Restricting activity has face validity as an important 
concern for elderly people, recognised over 30 years ago in the US Surgeon General’s 
Healthy People Report.33-35 It has been extensively used in the elderly care literature where it 
has been a key outcome measure in several clinical trials of interventions.35-39  
 
Statistical analysis 
Using date of death as the anchor, descriptive statistics presented the number and percentage 
of participants reporting breathlessness at each month before death. We calculated the total 
number of months participants reported restricting breathlessness during the last year of life 
and evaluated its relationship with the condition leading to death, plotting this relationship as 
a percentage of the total possible number of months. If participants died during the first year 
of follow-up, the denominator was the number of months with available data. 
We used percentage of months with restricting breathlessness during the last year as the 
outcome variable rather than a binary outcome (presence/absence) to provide a quantitative 
measure of restricting breathlessness. We investigated the relationships between percentage 
11 
 
months of restricting breathlessness and possible associated variables recorded before the 
final year (the most recent comprehensive assessment prior to the last year of life), using two 
sample t tests or linear regression. From the monthly follow-up data during the last year of 
life we calculated the percentage of months for which possible associated variables, and 
proxy measures were recorded and tested their associations with months of restricting 
breathlessness using multiple regression. Candidate variables were drawn from the literature 
and can be seen in table 2. 
We used multiple regression to investigate demographic and associated clinical factors, 
which had an effect identified in the unifactorial analysis and others with a plausible 
biological rationale or have been previously reported in the literature.40 These were included 
in a multiple regression analysis using stepwise analysis with backwards elimination. At each 
stage, the variable with the largest non-significant P value was removed and the step repeated 
until there were no non-significant associated factors.  
To assess the effect of using a mixture of participant and proxy measures, the stepwise 
regression model included the proportion of proxy measures as an associated factor.  
The appropriateness of the regression model was tested by examining residuals.  Histograms 
and scatter plots were inspected for non-Normal distribution and non-linearity.  Analyses 
were carried out by MB and MJ using Stata 12 (StataCorp, 2011, College Station, Texas). 
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RESULTS 
Of the 548 decedents in the analytic sample, 61.2% were women. Ethnicity was coded as 
“white” (91.2%) or “other” (8.8%). The mean age at death was 86.7 years (SD 6.0; range 71 
to 106; median age 87; IQR 83 to 91). Most were ex-smokers (59%) or current smokers (6%). 
This sample was representative of the main New Haven elderly cohort (64.6% women; 
90.5% “white”), but has more “white” people and, as expected in an older group, more 
women than in the general population in that region (79.3% “white”; 51.7% female).41     
Restricting breathlessness by condition leading to death 
The proportion of participants reporting restricting breathlessness at each month time-point 
during the last year of life (Figure 1) increases closer to death. 
<< insert Fig.1 about here>> 
Temporal patterns of restricting breathlessness 
Overall, 311/548 (56.8%) participants were reported to have restricting breathlessness at 
some point during the last year of life. Table 1 shows the participants who reported restricting 
breathlessness in the month before death and who reported this symptom in consecutive 
months prior to death, that is, those who presented with new breathlessness during the last 
year of life and continued with this symptom until death. No participant had restricting 
breathlessness reported at every month, and very few fitted the category “breathlessness that 
commenced partway through the year and continued”, for example, only 4 participants 
developed breathlessness during the last year and continued with reported breathlessness 
until death.  
<< insert Table 1 about here>> 
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Some of these participants may have had earlier restricting breathlessness episodes as well.  
Only about half (148/311) of those who reported restricting breathlessness at some time in the 
last year, were restricted by breathlessness one month before death. From the original 
hypotheses regarding temporal patterns of breathlessness during the last year, only 
“intermittent” and “crescendo” were observed.  
When displayed as restricting breathlessness per month according to the condition leading to 
death, breathlessness was most commonly reported for those who died from organ failure. 
This can be seen graphically in Figure 2, which shows increasing prevalence as death nears.   
<<insert Fig.2 about here>> 
Selection of potential variables associated with restricting breathlessness during the last 
year of life: unifactorial analyses 
Candidate factors with a plausible rationale and a statistically significant association with 
breathlessness in the last year of life on unifactorial analysis were: i) (when a problem was 
identified in the monthly report) mobility problems; depression; anxiety and, from death 
certificate data,  the condition leading to death; and ii) from the most recent comprehensive 
assessment prior to the last year of life: age; frailty; gender; physicians’ diagnoses; peak 
expiratory flow rate (PEFR); smoking status. The condition leading to death was a six-level 
factor (cancer, dementia, organ failure, frailty, sudden, other) and was tested together, rather 
than by individual t tests.  Smoking was a three-level factor (current, ex-smoker, never) and 
was also treated as a composite. Educational level was included due to its plausible impact 
and reported association with breathlessness in previous work.40. Other physician-diagnosed 
conditions such as arthritis, hip fracture, hypertension or diabetes mellitus had no rationale, 
nor unifactorial significance and were excluded. Ethnicity was not significant on unifactorial 
analysis.  (See Table 2) 
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<< insert Table 2 about here>> 
Predictors of restricting breathlessness during the last year of life: multifactorial 
analysis 
The final multifactorial model is shown in Table 3.  Percentage months of restricting 
breathlessness was associated with percentage months of anxiety, depression, and mobility 
problems reported during the last year of life, and a history of chronic lung disease, 
congestive heart failure, being an ex-smoker from the most recent comprehensive assessment, 
and having cancer, organ failure or other categories as the condition leading to death rather 
than frailty, dementia or sudden death.   Percentage months of restricting breathlessness 
decreased with higher educational attainment and age at death.   
For associated factors identified from the comprehensive assessment recorded as present or 
absent e.g. chronic lung disease, the coefficient represents the change in percentage of 
months with breathlessness if the diagnosis is present.  For associated factors recorded as 
percentage of months where the factor is reported during the last year of life, the coefficient 
represents the change in percentage months with breathlessness for each percentage point of 
months with this report.  Thus an increase of one percentage point in months of anxiety is 
related to an increase of 0.25 in percentage months of breathlessness.  Age is in years, so an 
increase of one year is related to a 0.23 reduction in percentage months with breathlessness. 
Testing of the regression model confirmed acceptable analyses. 
<<insert Table 3 about here>> 
Proxy measures for restricting breathlessness were obtained for 418 participants, including 
177 with partial proxy data and 241 with complete proxy data.  In the last year of life, the 
proportion of proxy measures increased slowly for the first nine months from (37% to 45%), 
and more rapidly over the last three months of life (49%; 57%; 70%).  To assess the effect of 
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using a mixture of participant and proxy measures, stepwise regression included the 
proportion of proxy measures as an associated factor.  It did not contribute to the final model. 
We also regressed the percentage of months with breathlessness on proportion of proxies but 
the relationship was not significant (P=0.40). It was felt that, in such a regression analysis, 
this approach was an appropriate and sufficiently robust method to assess the influence of 
proxy measurement and demonstrated that the analysis was not materially affected by proxy 
measures.  
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DISCUSSION 
These data show that during the last year of life, over 50% of community-living elderly 
people experienced breathlessness severe enough to restrict activity. Only half of those who 
reported breathlessness at some point during their last year had breathlessness during their 
last month. Few people (10%) had restricting breathlessness until a few months before their 
death. This prevalence may be considered lower than expected given previous community 
studies of older people (e.g. 32.3 to 37%)4, 6, but these studies used an outcome of MRC ≥3 
(”On level ground, I walk slower than people of the same age because of breathlessness, or 
have to stop for breath when walking at my own pace”) which is likely to represent a much 
less severe level of breathlessness than that measured in this study.    
The prevalence of breathlessness increased in the last few months prior to death for all 
conditions leading to death, including dementia and sudden death. Sudden death due to 
cardiac arrhythmia is associated with heart failure and an increase in breathlessness could 
reflect worsening of the heart condition. The finding that breathlessness increased prior to 
death in people dying with dementia is consistent with a retrospective study of nursing home 
residents with advanced dementia which found the presence of breathlessness to be a poor 
prognostic indicator.42 Even in the setting of dementia, the impact of increasing 
breathlessness speaks to the prevalence of this symptom irrespective of the underlying 
etiology, and the importance of breathlessness as a prognostic factor.  
 
Although the prevalence of breathlessness is known to be higher in older people when 
compared with younger people, within this elderly population, age was inversely related to 
restricting breathlessness during their last year. Restricting breathlessness was also associated 
with a diagnosis of heart and lung disease, mobility problems, anxiety and depression, 
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smoking status and with cancer as a condition leading to death. It may be that  those living to 
older old age have lived to such an age because they do not have the medical conditions 
associated with restricting breathlessness.  
The strong association between anxiety documented during monthly interviews and 
restricting breathlessness during the last year is consistent with other literature which 
describes anxiety as both a driver and a consequence of breathlessness,43 although causality 
cannot be inferred from these data. The similarly strong association seen for depression noted 
at monthly interviews and restricting breathlessness during the last year, was not found for 
depression reported at the last comprehensive assessment prior to death. This may indicate 
that breathlessness contributes to depression in this population. Depression is prevalent in 
people with chronic conditions and cancer, adversely impacting on quality of life, adherence 
with management and days at home.44 These new data confirm the importance of diagnosis 
and management of this potentially reversible co-morbidity.  
Although there are reports that women report more dyspnea for the same workload than 
men,40, 45, 1, 8 we did not find an excess of reported breathlessness in women.  
Mobility problems were associated with breathlessness; it is interesting to note that there is 
trial evidence to support the use of mobility aids to improve breathlessness.46  
 
Implications for clinical practice and future research 
The increased prevalence of restricting breathlessness in the months prior to death in each of 
the etiological sub-groups suggests that breathlessness is part of a final common pathway at 
the end of life. The presence, therefore, of this symptom should be systematically identified, 
assessed and managed in order to ensure optimal symptom management at the end of life, and 
optimal care planning in the light of its association with poor prognosis. However, although a 
trajectory pattern of escalating breathlessness was seen in some individuals, it was not 
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inevitable that a participant reporting restricting breathlessness would continue with this 
symptom until death. 
 
Strengths and Limitations 
Strengths of the present study include its prospective, repeated-measures design with 
standardized and comprehensive assessments including monthly reports with high rates of 
participation and follow up. Prospective assessment of self-reported symptoms, rather than a 
reliance on administrative or registry based data, is vital as older persons may not seek 
medical attention despite severe and prolonged symptomatology.49  
With the exception of ethnicity, the cohort demographics reflect the US general population 
well.26 The study cohort oversampled people at enrollment with an intermediate and high risk 
for disability, but rates of disability or symptoms were not affected.50  
 
“Restricting breathlessness” is not a familiar outcome in the palliative care or respiratory 
literature, in which measures of intensity, mastery or exercise tolerance are more often used 
such as the MRC dyspnea scale. 47 Like the MRC scale, it is a subjective measure and relative 
to what the participant counts as usual daily activities. These results indicate that restricted 
activity is a practical way to quantify the impact on people who experience restricting 
breathlessness. Functional status is known to be a useful prognostic indicator,48 and further 
work is indicated to explore further whether breathlessness sufficient to affect function is also 
a useful marker of deterioration.  
The dataset has proved immensely valuable in increasing understanding of the experience of 
the elderly over time, and the effect of many health issues on their independence and ability 
to conduct activities of daily living. Furthermore, we specifically wished to investigate 
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breathlessness which was bad enough to potentially affect independent living, and thus this 
definition of restricting breathlessness was fit for our purpose. 
 
We cannot comment on the number of days with restricted activity or the symptom severity, 
except that all reports relate to breathlessness sufficient to restrict activities, therefore all 
reports are of direct relevance to the respondents.  
 
CONCLUSION 
This analysis of data from a longstanding longitudinal study adds to the understanding of 
clinically relevant breathlessness in the elderly in the last year of life. Restricting 
breathlessness increased in this elderly population in the months preceding death from any 
cause. The data suggest that ageing per se may not cause breathlessness in the absence of 
other pathology. Data may indicate that depression was a response to restricting 
breathlessness. These data suggest that breathlessness may be part of a final common 
pathway very late in life. This symptom should therefore be systematically assessed and 
managed in the likely context of poor prognosis.   
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GRAPHICS 
 
Table 1. The Month of First Restricting Breathlessness which continued until the Month 
of Death. 
 frequency percentage 
Not breathless in last month 400              73.0 
Breathless reported in the last month  148  27.0 
 Breathless for 4 months before death           4 0.7  
 Breathless for 3 months before death          12 2.2  
 Breathless for 2 months before death           29 5.3  
 Breathless for month in which death 
occurred but not previous month 
 103 18.9 
Total  548        100.0 
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Table 2. Unifactorial analysis of candidate predictors 
Candidate predictor 
variables, and source 
coefficient 95% confidence 
intervals 
Unifactorial analysis (P 
value) 
FACTORS FROM MOST RECENT COMPREHENSIVE ASSESSMENT PRIOR TO LAST YEAR OF LIFE 
Age -0.32 -0.53 to -0.12  0.002  
NB – inverse relationship    
Frailty*  −0.56 -3.13  to  2.02 0.7 
Mobility ** 0.080 0.042 to 0.118 <0.001 
Gender(female) 0.79 −1.70 to 3.78 0.5       
Proxy measures 1.18    -1.64 to  4.00 0.41 
Peak expiratory flow rate -0.04    -0.08 to   0.01 0.1 
Smoking status 4.40   1.90 to   6.91 0.001 
Congestive Heart failure 
Chronic Lung disease 
Heart attack 
Cancer 
Stroke 
Arthritis 
Hip fracture 
Hypertension 
Diabetes mellitus 
3.68 
8.73 
2.24 
1.67 
3.62 
1.43 
0.38 
−0.69 
0.25 
0.39 to 6.97 
6.00 to 11.45 
−0.56 to 5.04 
−1.12 to 4.46 
0.30 to 6.95 
−0.99 to 3.85 
−3.52 to 4.27 
−3.20 to 1.81 
−2.60 to 3.10 
0.03  
<0.001 
0.1 
0.2 
0.03 
0.2 
0.9 
0.6 
0.9 
Condition leading to 
death: 
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cancer 
dementia 
organ failure 
sudden death 
frailty 
1.17 
−5.35 
5.46 
−7.18 
−2.30 
−3.11 to 5.45 
−9.66 to −1.04 
1.31  to 9.60 
−15.20 to 0.84 
−6.25 to 1.66 
< 0.001 
 
 
 
 
Educational level -0.05    -0.47 to   0.36 
 
0.8 
“White” Ethnicity -0.24    -0.50 to  0.02 0.07 
Depression (Center for 
Epidemiologic Studies-
Depression Scale) yes/no 
1.35 −1.42 to 4.13 0.3           
FACTORS FROM MONTHLY INTERVIEWS DURING THE LAST YEAR OF LIFE 
Self report anxiety, 
present or absent 
0.44 0.38 to  0.50 
 
< 0.001      
Self report depression, 
present or absent 
0.49    0.33 to  0.46 < 0.001      
Problems with mobility 0.08    0.04 to  0.12 < 0.001      
*Frailty = >3 of: Slow gait, weight loss, exhaustion, inactivity and reduced grip strength 
**Mobility problems= the need for personal assistance or unable to walk one quarter of a 
mile or unable to climb one flight of stairs 
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Table 3. Final Regression Model investigating Factors Associated with the Presence of 
Percentage Months of Reported Breathlessness during the Last Year of Life 
 Coefficient    Standard  
Error       
t P>|t|      [95% Confidence 
Interval] 
PREDICTIVE FACTORS FROM MONTHLY INTERVIEWS DURING THE LAST YEAR OF LIFE 
Depression*  
(Self report,  present or absent) 
0.14 0.05 3.0
2 
0.003 0.05 to 0.24 
Mobility problems* 
(Self report,  present or absent) 
0.07 0.02 3.8
5 
<0.001 0.03 to 0.11 
Anxiety* 
(Self report,  present or absent) 
0.25 0.05 5.2
4 
<0.001 0.16 to 0.34 
PREDICTIVE FACTORS FROM MOST RECENT COMPREHENSIVE ASSESSMENT PRIOR TO LAST YEAR OF LIFE 
Educational attainment ─0.47 0.17 ─2.
76 
0.006 ─0.80 to ─0.13 
Chronic lung disease 6.62 1.18 5.6
2 
<0.001 4.31 to 8.94 
Congestive heart failure 3.34 1.34 2.5
0 
0.013 0.71 to 5.97 
Condition leading to death 
Cancer 3.25 1.53 2.1
2 
0.034 0.24 to 6.25 
Other condition 3.64 1.71 2.1
2 
0.034 0.27 to 7.00 
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Dementia ─0.81 1.49 ─0.
54 
0.586 ─3.75 to 2.12 
Organ failure 4.19 1.41 2.9
7 
0.003 1.41 to 6.96 
Sudden death 0.32 3.26 0.1
0 
0.923 ─6.08 to 6. 
Age one year prior to death ─0.19 0.09 ─2.
17 
0.030 ─0.37 to ─0.02 
Smoking status 
Ex-smoker 3.01 1.05      2.8
6    
0.004      0.94 to  5.07 
Never smokers 1.28    2.17      0.5
9    
0.554     ─2.97 to 5.54 
constant 16.48    8.02     2.0
6    
 0.73 to  32.24 
*percentage months reported during the last year of life 
P = probability 
For an explanation of the meaning of the co-efficient, see text 
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Figure 1. Percentage of participants reporting restricting breathlessness at each month 
during the last year of life 
 
Figure 2. The percentage of participants reporting restricting breathlessness at each 
month during the last year of life by condition leading to death 
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